Novartis Invests $7.5M to Promote Early Prostate Cancer Testing in Vulnerable Communities
Novartis commits $7.5 million to the "Blitz the Barriers" campaign, aiming to raise awareness and encourage early testing for ...
Pharm Exec3d
Novartis Commits $75 Million to ZERO Prostate Cancer Initiative
According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.
FiercePharma5d
Novartis pumps $7.5M into push to save 100,000 lives from prostate cancer by 2035
Novartis has committed $7.5 million to an initiative aiming to save 100,000 lives by 2035. The money will launch Zero ...
Big pharma sues GenesisCare over Labor-endorsed copycat cancer drug
Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund ...
Atlanta Journal-Constitution8h
Beyoncé’s dad survived cancer. Now he’s on a mission to spread awareness
Beyoncé’s dad teamed up with ZERO Prostate Cancer to tackle the disease. Learn how this game-changing campaign is breaking stigma, expanding screenings and saving lives.
ZERO Prostate Cancer Launches Bold $20 Million 'Blitz The Barriers' Initiative to Close Gaps in Prostate Cancer Survival in Highest-Risk Communities
ZERO Prostate Cancer (ZERO), the nation's leading advocacy and support foundation for prostate cancer awareness, has announced the launch of Blitz the Barriers during Cancer Prevention Month. This ...
precisionmedicineonline4d
Real-World Studies Aim to Optimize Treatment Sequence for Novarits' Pluvicto in Prostate Cancer
Researchers explored how Pluvicto is used in the community and academic settings and when given by oncologists or urologists.
FiercePharma19d
TV drug ad spending reached new heights in January, as Novartis' Pluvicto toppled AbbVie's Skyrizi for top spot
According to iSpot.TV’s analysis of January TV drug ad spending data, Novartis’ prostate cancer drug Pluvicto swooped in to take the No. 1 spot on the list, with more than $47 million spent ...